314 related articles for article (PubMed ID: 28174259)
1. Proinflammatory Cytokines Predict the Incidence and Progression of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study.
Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Heier M; Püttgen S; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
Diabetes Care; 2017 Apr; 40(4):569-576. PubMed ID: 28174259
[TBL] [Abstract][Full Text] [Related]
2. Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study.
Herder C; Bongaerts BW; Rathmann W; Heier M; Kowall B; Koenig W; Thorand B; Roden M; Meisinger C; Ziegler D
Diabetes Care; 2013 Nov; 36(11):3663-70. PubMed ID: 24009302
[TBL] [Abstract][Full Text] [Related]
3. Associations between multiple neurological biomarkers and distal sensorimotor polyneuropathy: KORA F4/FF4 study.
Herder C; Thorand B; Strom A; Rathmann W; Heier M; Koenig W; Morrison H; Ziegler D; Roden M; Peters A; Bönhof GJ; Maalmi H
Diabetes Metab Res Rev; 2024 Jul; 40(5):e3807. PubMed ID: 38872492
[TBL] [Abstract][Full Text] [Related]
4. Differential association between biomarkers of subclinical inflammation and painful polyneuropathy: results from the KORA F4 study.
Herder C; Bongaerts BW; Rathmann W; Heier M; Kowall B; Koenig W; Thorand B; Roden M; Meisinger C; Ziegler D
Diabetes Care; 2015 Jan; 38(1):91-6. PubMed ID: 25325880
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study.
Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Strom A; Bönhof GJ; Heier M; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
Diabetes Metab Res Rev; 2018 Jul; 34(5):e3000. PubMed ID: 29577557
[TBL] [Abstract][Full Text] [Related]
6. A Systemic Inflammatory Signature Reflecting Cross Talk Between Innate and Adaptive Immunity Is Associated With Incident Polyneuropathy: KORA F4/FF4 Study.
Herder C; Kannenberg JM; Carstensen-Kirberg M; Strom A; Bönhof GJ; Rathmann W; Huth C; Koenig W; Heier M; Krumsiek J; Peters A; Meisinger C; Roden M; Thorand B; Ziegler D
Diabetes; 2018 Nov; 67(11):2434-2442. PubMed ID: 30115651
[TBL] [Abstract][Full Text] [Related]
7. General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 Cohort.
Schlesinger S; Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Bönhof GJ; Koenig W; Heier M; Peters A; Meisinger C; Roden M; Thorand B; Ziegler D
Diabetes Care; 2019 Feb; 42(2):240-247. PubMed ID: 30523031
[TBL] [Abstract][Full Text] [Related]
8. Association of Long-Term Air Pollution with Prevalence and Incidence of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study.
Herder C; Schneider A; Zhang S; Wolf K; Maalmi H; Huth C; Pickford R; Laxy M; Bönhof GJ; Koenig W; Rathmann W; Roden M; Peters A; Thorand B; Ziegler D
Environ Health Perspect; 2020 Dec; 128(12):127013. PubMed ID: 33356516
[TBL] [Abstract][Full Text] [Related]
9. Low serum omentin levels in the elderly population with Type 2 diabetes and polyneuropathy.
Herder C; Bongaerts BW; Ouwens DM; Rathmann W; Heier M; Carstensen-Kirberg M; Koenig W; Thorand B; Roden M; Meisinger C; Ziegler D;
Diabet Med; 2015 Nov; 32(11):1479-83. PubMed ID: 26094489
[TBL] [Abstract][Full Text] [Related]
10. Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy.
Ziegler D; Strom A; Bönhof GJ; Kannenberg JM; Heier M; Rathmann W; Peters A; Meisinger C; Roden M; Thorand B; Herder C
BMJ Open Diabetes Res Care; 2019; 7(1):e000752. PubMed ID: 31803481
[TBL] [Abstract][Full Text] [Related]
11. Environmental risk factors of incident distal sensorimotor polyneuropathy: Results from the prospective population-based KORA F4/FF4 study.
Herder C; Zhang S; Wolf K; Maalmi H; Bönhof GJ; Rathmann W; Schwettmann L; Thorand B; Roden M; Schneider A; Ziegler D; Peters A
Sci Total Environ; 2023 Feb; 858(Pt 3):159878. PubMed ID: 36328258
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes.
Schamarek I; Herder C; Nowotny B; Carstensen-Kirberg M; Straßburger K; Nowotny P; Strom A; Püttgen S; Müssig K; Szendroedi J; Roden M; Ziegler D;
Eur J Endocrinol; 2016 Apr; 174(4):433-43. PubMed ID: 26733478
[TBL] [Abstract][Full Text] [Related]
13. Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 study.
Herder C; Kannenberg JM; Niersmann C; Huth C; Carstensen-Kirberg M; Wittenbecher C; Schulze M; Blüher M; Rathmann W; Peters A; Roden M; Meisinger C; Thorand B
Eur J Endocrinol; 2017 Oct; 177(4):277-286. PubMed ID: 28679518
[TBL] [Abstract][Full Text] [Related]
14. Effect of obesity on the associations of 25-hydroxyvitamin D with prevalent and incident distal sensorimotor polyneuropathy: population-based KORA F4/FF4 study.
Maalmi H; Herder C; Huth C; Rathmann W; Bönhof GJ; Heier M; Koenig W; Roden M; Peters A; Ziegler D; Thorand B
Int J Obes (Lond); 2022 Jul; 46(7):1366-1374. PubMed ID: 35474356
[TBL] [Abstract][Full Text] [Related]
15. Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: the KORA F4 study.
Bongaerts BW; Rathmann W; Heier M; Kowall B; Herder C; Stöckl D; Meisinger C; Ziegler D
Diabetes Care; 2013 May; 36(5):1141-6. PubMed ID: 23275355
[TBL] [Abstract][Full Text] [Related]
16. Low serum bilirubin levels contribute to the presence and progression of distal symmetrical polyneuropathy in Chinese patients with type 2 diabetes.
Jin J; Wang W; Gu T; Chen C; Sun J; Chen W; Bi Y; Zhu D
Diabetes Metab; 2019 Jan; 45(1):47-52. PubMed ID: 29555465
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10).
Kamiya H; Himeno T; Watarai A; Baba M; Nishimura R; Tajima N; Nakamura J
J Diabetes Investig; 2024 Feb; 15(2):247-253. PubMed ID: 38213265
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study.
Herder C; Kannenberg JM; Carstensen-Kirberg M; Huth C; Meisinger C; Koenig W; Peters A; Rathmann W; Roden M; Thorand B
Cardiovasc Diabetol; 2017 Jan; 16(1):17. PubMed ID: 28143481
[TBL] [Abstract][Full Text] [Related]
19. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of inflammatory factors are associated with severity of polyneuropathy in type 1 diabetes.
Okdahl T; Brock C; Fløyel T; Wegeberg AL; Jakobsen PE; Ejskjaer N; Pociot F; Brock B; Størling J
Clin Endocrinol (Oxf); 2020 Oct; 93(4):419-428. PubMed ID: 32497255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
